Diagnostic Research of CT Combined with Serum CA125 and HE4 in Ovarian Epithelial Malignant Tumor
Objective: To explore the diagnostic value of CT combined with serum CA125 and HE4 in ovarian epithelial malignant tumor. Methods: 156 cases of epithelial ovarian tumors (benign 72 cases, malignant 84 cases) were studied. Detections of CT and serum tumor markers CA125 and HE4 were carried out before...
Main Authors: | Desheng WANG, Fanggong KAN, Zhoupeng MA |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Office of Computerized Tomography Theory and Application
2022-10-01
|
Series: | CT Lilun yu yingyong yanjiu |
Subjects: | |
Online Access: | https://www.cttacn.org.cn/cn/article/doi/10.15953/j.1004-4140.2022.31.05.13 |
Similar Items
-
Are ROMA and HE4 more accurate than CA-125, in predicting of ovarian epithelial carcinoma?
by: Fariba Behnamfar, et al.
Published: (2023-01-01) -
Correlation of Molecular Tumor Markers CA125, HE4, and CEA with the Development and Progression of Epithelial Ovarian Cancer
by: Qiuhua Wan, et al.
Published: (2021-06-01) -
The Role of Salivary and Serum Ca125 and Routine Blood Tests in Patients with Ovarian Malignancies
by: Ante Vuković, et al.
Published: (2021-01-01) -
Immunohistochemical Study of the CD44 Expression in Benign, Borderline and Malignant Surface Epithelial Ovarian Tumors and Metastatic Ovarian Tumors
by: Gamze Yurdakan, et al.
Published: (2007-12-01) -
HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial
by: Michel Fabbro, et al.
Published: (2024-01-01)